nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—CYP1A2—Carmustine—lymphatic system cancer	0.204	0.334	CbGbCtD
Azithromycin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0837	0.137	CbGbCtD
Azithromycin—CYP3A4—Cytarabine—lymphatic system cancer	0.0728	0.12	CbGbCtD
Azithromycin—CYP3A4—Teniposide—lymphatic system cancer	0.0717	0.118	CbGbCtD
Azithromycin—ABCB1—Vincristine—lymphatic system cancer	0.0576	0.0946	CbGbCtD
Azithromycin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0502	0.0824	CbGbCtD
Azithromycin—ABCB1—Methotrexate—lymphatic system cancer	0.0349	0.0573	CbGbCtD
Azithromycin—CYP3A4—Vincristine—lymphatic system cancer	0.0345	0.0567	CbGbCtD
Azithromycin—Dyspepsia—Fludarabine—lymphatic system cancer	0.0007	0.00179	CcSEcCtD
Azithromycin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000696	0.00178	CcSEcCtD
Azithromycin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000692	0.00177	CcSEcCtD
Azithromycin—Visual impairment—Carmustine—lymphatic system cancer	0.000691	0.00177	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000687	0.00176	CcSEcCtD
Azithromycin—Fatigue—Fludarabine—lymphatic system cancer	0.000686	0.00175	CcSEcCtD
Azithromycin—Inflammation—Methotrexate—lymphatic system cancer	0.000682	0.00174	CcSEcCtD
Azithromycin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000681	0.00174	CcSEcCtD
Azithromycin—Pain—Fludarabine—lymphatic system cancer	0.00068	0.00174	CcSEcCtD
Azithromycin—Constipation—Fludarabine—lymphatic system cancer	0.00068	0.00174	CcSEcCtD
Azithromycin—Vasculitis—Methotrexate—lymphatic system cancer	0.000677	0.00173	CcSEcCtD
Azithromycin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000668	0.00171	CcSEcCtD
Azithromycin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000667	0.00171	CcSEcCtD
Azithromycin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000666	0.0017	CcSEcCtD
Azithromycin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000663	0.0017	CcSEcCtD
Azithromycin—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000661	0.00169	CcSEcCtD
Azithromycin—Anaemia—Bleomycin—lymphatic system cancer	0.000661	0.00169	CcSEcCtD
Azithromycin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000656	0.00168	CcSEcCtD
Azithromycin—Asthenia—Teniposide—lymphatic system cancer	0.00065	0.00166	CcSEcCtD
Azithromycin—Melaena—Methotrexate—lymphatic system cancer	0.000646	0.00165	CcSEcCtD
Azithromycin—Malaise—Bleomycin—lymphatic system cancer	0.000645	0.00165	CcSEcCtD
Azithromycin—Pruritus—Teniposide—lymphatic system cancer	0.000641	0.00164	CcSEcCtD
Azithromycin—Arrhythmia—Carmustine—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Azithromycin—Leukopenia—Bleomycin—lymphatic system cancer	0.00064	0.00164	CcSEcCtD
Azithromycin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000629	0.00161	CcSEcCtD
Azithromycin—Vaginal infection—Methotrexate—lymphatic system cancer	0.000624	0.0016	CcSEcCtD
Azithromycin—Cough—Bleomycin—lymphatic system cancer	0.000624	0.0016	CcSEcCtD
Azithromycin—Diarrhoea—Teniposide—lymphatic system cancer	0.000619	0.00158	CcSEcCtD
Azithromycin—Chest pain—Bleomycin—lymphatic system cancer	0.000609	0.00156	CcSEcCtD
Azithromycin—Myalgia—Bleomycin—lymphatic system cancer	0.000609	0.00156	CcSEcCtD
Azithromycin—Discomfort—Bleomycin—lymphatic system cancer	0.000601	0.00154	CcSEcCtD
Azithromycin—Chills—Mitoxantrone—lymphatic system cancer	0.000598	0.00153	CcSEcCtD
Azithromycin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000595	0.00152	CcSEcCtD
Azithromycin—Vision blurred—Carmustine—lymphatic system cancer	0.000588	0.0015	CcSEcCtD
Azithromycin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000586	0.0015	CcSEcCtD
Azithromycin—Oedema—Bleomycin—lymphatic system cancer	0.000583	0.00149	CcSEcCtD
Azithromycin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000583	0.00149	CcSEcCtD
Azithromycin—Infection—Bleomycin—lymphatic system cancer	0.00058	0.00148	CcSEcCtD
Azithromycin—Anaemia—Carmustine—lymphatic system cancer	0.000577	0.00148	CcSEcCtD
Azithromycin—Vomiting—Teniposide—lymphatic system cancer	0.000576	0.00147	CcSEcCtD
Azithromycin—Agitation—Carmustine—lymphatic system cancer	0.000573	0.00147	CcSEcCtD
Azithromycin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000571	0.00146	CcSEcCtD
Azithromycin—Asthenia—Fludarabine—lymphatic system cancer	0.000571	0.00146	CcSEcCtD
Azithromycin—Rash—Teniposide—lymphatic system cancer	0.000571	0.00146	CcSEcCtD
Azithromycin—Dermatitis—Teniposide—lymphatic system cancer	0.00057	0.00146	CcSEcCtD
Azithromycin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000568	0.00145	CcSEcCtD
Azithromycin—Headache—Teniposide—lymphatic system cancer	0.000567	0.00145	CcSEcCtD
Azithromycin—Pruritus—Fludarabine—lymphatic system cancer	0.000563	0.00144	CcSEcCtD
Azithromycin—Leukopenia—Carmustine—lymphatic system cancer	0.000559	0.00143	CcSEcCtD
Azithromycin—Anorexia—Bleomycin—lymphatic system cancer	0.000556	0.00142	CcSEcCtD
Azithromycin—Anaemia—Vincristine—lymphatic system cancer	0.000551	0.00141	CcSEcCtD
Azithromycin—Agitation—Vincristine—lymphatic system cancer	0.000547	0.0014	CcSEcCtD
Azithromycin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000547	0.0014	CcSEcCtD
Azithromycin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000547	0.0014	CcSEcCtD
Azithromycin—Hypotension—Bleomycin—lymphatic system cancer	0.000545	0.00139	CcSEcCtD
Azithromycin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000544	0.00139	CcSEcCtD
Azithromycin—Convulsion—Carmustine—lymphatic system cancer	0.000541	0.00138	CcSEcCtD
Azithromycin—Hypertension—Carmustine—lymphatic system cancer	0.000539	0.00138	CcSEcCtD
Azithromycin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000538	0.00138	CcSEcCtD
Azithromycin—Nausea—Teniposide—lymphatic system cancer	0.000538	0.00138	CcSEcCtD
Azithromycin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000536	0.00137	CcSEcCtD
Azithromycin—Vertigo—Vincristine—lymphatic system cancer	0.000535	0.00137	CcSEcCtD
Azithromycin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000534	0.00137	CcSEcCtD
Azithromycin—Leukopenia—Vincristine—lymphatic system cancer	0.000533	0.00136	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000532	0.00136	CcSEcCtD
Azithromycin—Chest pain—Carmustine—lymphatic system cancer	0.000531	0.00136	CcSEcCtD
Azithromycin—Myalgia—Carmustine—lymphatic system cancer	0.000531	0.00136	CcSEcCtD
Azithromycin—Anxiety—Carmustine—lymphatic system cancer	0.000529	0.00135	CcSEcCtD
Azithromycin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000524	0.00134	CcSEcCtD
Azithromycin—Malaise—Mitoxantrone—lymphatic system cancer	0.000523	0.00134	CcSEcCtD
Azithromycin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00052	0.00133	CcSEcCtD
Azithromycin—Renal failure acute—Methotrexate—lymphatic system cancer	0.00052	0.00133	CcSEcCtD
Azithromycin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000519	0.00133	CcSEcCtD
Azithromycin—Convulsion—Vincristine—lymphatic system cancer	0.000516	0.00132	CcSEcCtD
Azithromycin—Hypertension—Vincristine—lymphatic system cancer	0.000514	0.00132	CcSEcCtD
Azithromycin—Oedema—Carmustine—lymphatic system cancer	0.000509	0.0013	CcSEcCtD
Azithromycin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000509	0.0013	CcSEcCtD
Azithromycin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000507	0.0013	CcSEcCtD
Azithromycin—Myalgia—Vincristine—lymphatic system cancer	0.000507	0.0013	CcSEcCtD
Azithromycin—Cough—Mitoxantrone—lymphatic system cancer	0.000506	0.00129	CcSEcCtD
Azithromycin—Infection—Carmustine—lymphatic system cancer	0.000506	0.00129	CcSEcCtD
Azithromycin—Vomiting—Fludarabine—lymphatic system cancer	0.000506	0.00129	CcSEcCtD
Azithromycin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000503	0.00129	CcSEcCtD
Azithromycin—Rash—Fludarabine—lymphatic system cancer	0.000502	0.00128	CcSEcCtD
Azithromycin—Dermatitis—Fludarabine—lymphatic system cancer	0.000501	0.00128	CcSEcCtD
Azithromycin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000501	0.00128	CcSEcCtD
Azithromycin—Pain—Bleomycin—lymphatic system cancer	0.000499	0.00128	CcSEcCtD
Azithromycin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000499	0.00128	CcSEcCtD
Azithromycin—Headache—Fludarabine—lymphatic system cancer	0.000498	0.00128	CcSEcCtD
Azithromycin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000494	0.00126	CcSEcCtD
Azithromycin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000494	0.00126	CcSEcCtD
Azithromycin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000494	0.00126	CcSEcCtD
Azithromycin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000492	0.00126	CcSEcCtD
Azithromycin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000488	0.00125	CcSEcCtD
Azithromycin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Azithromycin—Oedema—Vincristine—lymphatic system cancer	0.000486	0.00124	CcSEcCtD
Azithromycin—Anorexia—Carmustine—lymphatic system cancer	0.000485	0.00124	CcSEcCtD
Azithromycin—Infection—Vincristine—lymphatic system cancer	0.000483	0.00124	CcSEcCtD
Azithromycin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000481	0.00123	CcSEcCtD
Azithromycin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000476	0.00122	CcSEcCtD
Azithromycin—Hypotension—Carmustine—lymphatic system cancer	0.000476	0.00122	CcSEcCtD
Azithromycin—Oedema—Mitoxantrone—lymphatic system cancer	0.000473	0.00121	CcSEcCtD
Azithromycin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000473	0.00121	CcSEcCtD
Azithromycin—Nausea—Fludarabine—lymphatic system cancer	0.000473	0.00121	CcSEcCtD
Azithromycin—Infection—Mitoxantrone—lymphatic system cancer	0.00047	0.0012	CcSEcCtD
Azithromycin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00047	0.0012	CcSEcCtD
Azithromycin—Shock—Mitoxantrone—lymphatic system cancer	0.000466	0.00119	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000464	0.00119	CcSEcCtD
Azithromycin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000464	0.00119	CcSEcCtD
Azithromycin—Urticaria—Bleomycin—lymphatic system cancer	0.000463	0.00119	CcSEcCtD
Azithromycin—Anorexia—Vincristine—lymphatic system cancer	0.000463	0.00119	CcSEcCtD
Azithromycin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000461	0.00118	CcSEcCtD
Azithromycin—Insomnia—Carmustine—lymphatic system cancer	0.000461	0.00118	CcSEcCtD
Azithromycin—Irritability—Methotrexate—lymphatic system cancer	0.000458	0.00117	CcSEcCtD
Azithromycin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000458	0.00117	CcSEcCtD
Azithromycin—Paraesthesia—Carmustine—lymphatic system cancer	0.000457	0.00117	CcSEcCtD
Azithromycin—Hypotension—Vincristine—lymphatic system cancer	0.000454	0.00116	CcSEcCtD
Azithromycin—Dyspnoea—Carmustine—lymphatic system cancer	0.000454	0.00116	CcSEcCtD
Azithromycin—Somnolence—Carmustine—lymphatic system cancer	0.000453	0.00116	CcSEcCtD
Azithromycin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000451	0.00115	CcSEcCtD
Azithromycin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000443	0.00113	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000443	0.00113	CcSEcCtD
Azithromycin—Decreased appetite—Carmustine—lymphatic system cancer	0.000443	0.00113	CcSEcCtD
Azithromycin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000442	0.00113	CcSEcCtD
Azithromycin—Insomnia—Vincristine—lymphatic system cancer	0.00044	0.00112	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00044	0.00112	CcSEcCtD
Azithromycin—Paraesthesia—Vincristine—lymphatic system cancer	0.000437	0.00112	CcSEcCtD
Azithromycin—Pain—Carmustine—lymphatic system cancer	0.000435	0.00111	CcSEcCtD
Azithromycin—Constipation—Carmustine—lymphatic system cancer	0.000435	0.00111	CcSEcCtD
Azithromycin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000432	0.00111	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000431	0.0011	CcSEcCtD
Azithromycin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00043	0.0011	CcSEcCtD
Azithromycin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000425	0.00109	CcSEcCtD
Azithromycin—Decreased appetite—Vincristine—lymphatic system cancer	0.000423	0.00108	CcSEcCtD
Azithromycin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000422	0.00108	CcSEcCtD
Azithromycin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000421	0.00108	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00042	0.00107	CcSEcCtD
Azithromycin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00042	0.00107	CcSEcCtD
Azithromycin—Fatigue—Vincristine—lymphatic system cancer	0.000419	0.00107	CcSEcCtD
Azithromycin—Asthenia—Bleomycin—lymphatic system cancer	0.000419	0.00107	CcSEcCtD
Azithromycin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000417	0.00107	CcSEcCtD
Azithromycin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000416	0.00107	CcSEcCtD
Azithromycin—Pain—Vincristine—lymphatic system cancer	0.000416	0.00106	CcSEcCtD
Azithromycin—Constipation—Vincristine—lymphatic system cancer	0.000416	0.00106	CcSEcCtD
Azithromycin—Asthma—Methotrexate—lymphatic system cancer	0.000415	0.00106	CcSEcCtD
Azithromycin—Pruritus—Bleomycin—lymphatic system cancer	0.000413	0.00106	CcSEcCtD
Azithromycin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000412	0.00105	CcSEcCtD
Azithromycin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000411	0.00105	CcSEcCtD
Azithromycin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000408	0.00104	CcSEcCtD
Azithromycin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000407	0.00104	CcSEcCtD
Azithromycin—Constipation—Mitoxantrone—lymphatic system cancer	0.000405	0.00104	CcSEcCtD
Azithromycin—Pain—Mitoxantrone—lymphatic system cancer	0.000405	0.00104	CcSEcCtD
Azithromycin—Abdominal pain—Carmustine—lymphatic system cancer	0.000403	0.00103	CcSEcCtD
Azithromycin—Body temperature increased—Carmustine—lymphatic system cancer	0.000403	0.00103	CcSEcCtD
Azithromycin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000398	0.00102	CcSEcCtD
Azithromycin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00039	0.000998	CcSEcCtD
Azithromycin—Neutropenia—Methotrexate—lymphatic system cancer	0.000388	0.000992	CcSEcCtD
Azithromycin—Dysuria—Methotrexate—lymphatic system cancer	0.000388	0.000992	CcSEcCtD
Azithromycin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000387	0.00099	CcSEcCtD
Azithromycin—Abdominal pain—Vincristine—lymphatic system cancer	0.000384	0.000983	CcSEcCtD
Azithromycin—Body temperature increased—Vincristine—lymphatic system cancer	0.000384	0.000983	CcSEcCtD
Azithromycin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000379	0.000969	CcSEcCtD
Azithromycin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000376	0.000962	CcSEcCtD
Azithromycin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000375	0.00096	CcSEcCtD
Azithromycin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000374	0.000957	CcSEcCtD
Azithromycin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000374	0.000957	CcSEcCtD
Azithromycin—Pneumonia—Methotrexate—lymphatic system cancer	0.000372	0.000952	CcSEcCtD
Azithromycin—Vomiting—Bleomycin—lymphatic system cancer	0.000371	0.000949	CcSEcCtD
Azithromycin—Infestation—Methotrexate—lymphatic system cancer	0.00037	0.000946	CcSEcCtD
Azithromycin—Infestation NOS—Methotrexate—lymphatic system cancer	0.00037	0.000946	CcSEcCtD
Azithromycin—Rash—Bleomycin—lymphatic system cancer	0.000368	0.000941	CcSEcCtD
Azithromycin—Dermatitis—Bleomycin—lymphatic system cancer	0.000367	0.00094	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000367	0.000938	CcSEcCtD
Azithromycin—Asthenia—Carmustine—lymphatic system cancer	0.000365	0.000935	CcSEcCtD
Azithromycin—Stomatitis—Methotrexate—lymphatic system cancer	0.00036	0.000922	CcSEcCtD
Azithromycin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000358	0.000916	CcSEcCtD
Azithromycin—Sweating—Methotrexate—lymphatic system cancer	0.000355	0.000907	CcSEcCtD
Azithromycin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000349	0.000892	CcSEcCtD
Azithromycin—Asthenia—Vincristine—lymphatic system cancer	0.000349	0.000892	CcSEcCtD
Azithromycin—Diarrhoea—Carmustine—lymphatic system cancer	0.000348	0.000891	CcSEcCtD
Azithromycin—Nausea—Bleomycin—lymphatic system cancer	0.000347	0.000887	CcSEcCtD
Azithromycin—Asthenia—Mitoxantrone—lymphatic system cancer	0.00034	0.000869	CcSEcCtD
Azithromycin—Dizziness—Carmustine—lymphatic system cancer	0.000337	0.000862	CcSEcCtD
Azithromycin—Diarrhoea—Vincristine—lymphatic system cancer	0.000333	0.000851	CcSEcCtD
Azithromycin—Hepatitis—Methotrexate—lymphatic system cancer	0.000332	0.000849	CcSEcCtD
Azithromycin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000324	0.000829	CcSEcCtD
Azithromycin—Vomiting—Carmustine—lymphatic system cancer	0.000324	0.000828	CcSEcCtD
Azithromycin—Dizziness—Vincristine—lymphatic system cancer	0.000321	0.000822	CcSEcCtD
Azithromycin—Rash—Carmustine—lymphatic system cancer	0.000321	0.000821	CcSEcCtD
Azithromycin—Dermatitis—Carmustine—lymphatic system cancer	0.000321	0.000821	CcSEcCtD
Azithromycin—Visual impairment—Methotrexate—lymphatic system cancer	0.00032	0.000819	CcSEcCtD
Azithromycin—Headache—Carmustine—lymphatic system cancer	0.000319	0.000816	CcSEcCtD
Azithromycin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000314	0.000803	CcSEcCtD
Azithromycin—Tinnitus—Methotrexate—lymphatic system cancer	0.00031	0.000792	CcSEcCtD
Azithromycin—Vomiting—Vincristine—lymphatic system cancer	0.000309	0.000791	CcSEcCtD
Azithromycin—Rash—Vincristine—lymphatic system cancer	0.000307	0.000784	CcSEcCtD
Azithromycin—Dermatitis—Vincristine—lymphatic system cancer	0.000306	0.000783	CcSEcCtD
Azithromycin—Headache—Vincristine—lymphatic system cancer	0.000305	0.000779	CcSEcCtD
Azithromycin—Nausea—Carmustine—lymphatic system cancer	0.000302	0.000774	CcSEcCtD
Azithromycin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000301	0.00077	CcSEcCtD
Azithromycin—Rash—Mitoxantrone—lymphatic system cancer	0.000298	0.000764	CcSEcCtD
Azithromycin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000298	0.000763	CcSEcCtD
Azithromycin—Chills—Methotrexate—lymphatic system cancer	0.000298	0.000762	CcSEcCtD
Azithromycin—Headache—Mitoxantrone—lymphatic system cancer	0.000297	0.000759	CcSEcCtD
Azithromycin—Nausea—Vincristine—lymphatic system cancer	0.000289	0.000739	CcSEcCtD
Azithromycin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000283	0.000724	CcSEcCtD
Azithromycin—Nausea—Mitoxantrone—lymphatic system cancer	0.000281	0.000719	CcSEcCtD
Azithromycin—Vision blurred—Methotrexate—lymphatic system cancer	0.000272	0.000697	CcSEcCtD
Azithromycin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000268	0.000686	CcSEcCtD
Azithromycin—Anaemia—Methotrexate—lymphatic system cancer	0.000267	0.000683	CcSEcCtD
Azithromycin—Malaise—Methotrexate—lymphatic system cancer	0.000261	0.000667	CcSEcCtD
Azithromycin—Vertigo—Methotrexate—lymphatic system cancer	0.00026	0.000664	CcSEcCtD
Azithromycin—Leukopenia—Methotrexate—lymphatic system cancer	0.000259	0.000662	CcSEcCtD
Azithromycin—Cough—Methotrexate—lymphatic system cancer	0.000252	0.000645	CcSEcCtD
Azithromycin—Convulsion—Methotrexate—lymphatic system cancer	0.00025	0.000641	CcSEcCtD
Azithromycin—Chest pain—Methotrexate—lymphatic system cancer	0.000246	0.000629	CcSEcCtD
Azithromycin—Myalgia—Methotrexate—lymphatic system cancer	0.000246	0.000629	CcSEcCtD
Azithromycin—Arthralgia—Methotrexate—lymphatic system cancer	0.000246	0.000629	CcSEcCtD
Azithromycin—Discomfort—Methotrexate—lymphatic system cancer	0.000243	0.000622	CcSEcCtD
Azithromycin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000236	0.000603	CcSEcCtD
Azithromycin—Infection—Methotrexate—lymphatic system cancer	0.000234	0.000599	CcSEcCtD
Azithromycin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000231	0.000591	CcSEcCtD
Azithromycin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000228	0.000583	CcSEcCtD
Azithromycin—Anorexia—Methotrexate—lymphatic system cancer	0.000225	0.000575	CcSEcCtD
Azithromycin—Hypotension—Methotrexate—lymphatic system cancer	0.00022	0.000564	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000215	0.00055	CcSEcCtD
Azithromycin—Insomnia—Methotrexate—lymphatic system cancer	0.000213	0.000546	CcSEcCtD
Azithromycin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000212	0.000542	CcSEcCtD
Azithromycin—Dyspnoea—Methotrexate—lymphatic system cancer	0.00021	0.000538	CcSEcCtD
Azithromycin—Somnolence—Methotrexate—lymphatic system cancer	0.00021	0.000536	CcSEcCtD
Azithromycin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000208	0.000531	CcSEcCtD
Azithromycin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000205	0.000525	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000204	0.000521	CcSEcCtD
Azithromycin—Fatigue—Methotrexate—lymphatic system cancer	0.000203	0.00052	CcSEcCtD
Azithromycin—Pain—Methotrexate—lymphatic system cancer	0.000202	0.000516	CcSEcCtD
Azithromycin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000194	0.000497	CcSEcCtD
Azithromycin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000193	0.000493	CcSEcCtD
Azithromycin—Urticaria—Methotrexate—lymphatic system cancer	0.000187	0.000479	CcSEcCtD
Azithromycin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000186	0.000477	CcSEcCtD
Azithromycin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000186	0.000477	CcSEcCtD
Azithromycin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000174	0.000445	CcSEcCtD
Azithromycin—Asthenia—Methotrexate—lymphatic system cancer	0.000169	0.000433	CcSEcCtD
Azithromycin—Pruritus—Methotrexate—lymphatic system cancer	0.000167	0.000427	CcSEcCtD
Azithromycin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000161	0.000413	CcSEcCtD
Azithromycin—Dizziness—Methotrexate—lymphatic system cancer	0.000156	0.000399	CcSEcCtD
Azithromycin—Vomiting—Methotrexate—lymphatic system cancer	0.00015	0.000384	CcSEcCtD
Azithromycin—Rash—Methotrexate—lymphatic system cancer	0.000149	0.00038	CcSEcCtD
Azithromycin—Dermatitis—Methotrexate—lymphatic system cancer	0.000149	0.00038	CcSEcCtD
Azithromycin—Headache—Methotrexate—lymphatic system cancer	0.000148	0.000378	CcSEcCtD
Azithromycin—Nausea—Methotrexate—lymphatic system cancer	0.00014	0.000358	CcSEcCtD
